STOCK TITAN

Boston Scientific announces conference call discussing first quarter 2026 results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Boston Scientific (NYSE: BSX) will webcast a conference call to discuss its first quarter ended March 31, 2026 results on April 22, 2026 at 8:00 a.m. ET.

The call will be hosted by Mike Mahoney, chairman and CEO, and Jon Monson, EVP and CFO. A news release with results will be issued before the call; live webcast and replay available at the company's investor site.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Key Figures

Earnings period end: March 31, 2026 Earnings call date: April 22, 2026 Earnings call time: 8:00 a.m. ET +1 more
4 metrics
Earnings period end March 31, 2026 First quarter 2026 reporting period referenced for upcoming call
Earnings call date April 22, 2026 Scheduled date for Q1 2026 results conference call
Earnings call time 8:00 a.m. ET Start time of the Q1 2026 webcast conference call
Replay availability ≈1 hour post-event Replay accessible about one hour after call completion

Market Reality Check

Price: $62.93 Vol: Volume 15,755,871 is 24% ...
normal vol
$62.93 Last Close
Volume Volume 15,755,871 is 24% above the 20-day average of 12,683,169. normal
Technical Price at 69.17 is trading below the 200-day MA of 94.95, and well under the 109.50 52-week high.

Peers on Argus

BSX is down 1.43% with elevated volume. All 5 major peers (SYK, MDT, EW, ABT, PH...

BSX is down 1.43% with elevated volume. All 5 major peers (SYK, MDT, EW, ABT, PHG) also show declines between -0.21% and -3.01%, indicating a broad Medical Devices downdraft rather than a BSX‑specific move.

Previous Conferences,earnings Reports

5 past events · Latest: Jan 02 (Neutral)
Same Type Pattern 5 events
Date Event Sentiment Move Catalyst
Jan 02 Earnings & conference plan Neutral -0.7% Outlined JPM conference appearance and Q4/FY 2025 earnings call timing.
Sep 02 Investor day & Q3 call Neutral +1.1% Announced 2025 Investor Day and Q3 2025 earnings conference call schedule.
Jul 01 Q2 2025 call setup Neutral -2.5% Set date and time for Q2 2025 earnings call and webcast access.
Apr 01 Q1 2025 call setup Neutral +0.4% Scheduled Q1 2025 results call with leadership and webcast details.
Jan 02 JPM & Q4 2024 call Neutral +0.1% Announced JPM conference participation and Q4 2024 earnings call timing.
Pattern Detected

Similar "conferences,earnings" scheduling announcements have historically led to modest share moves, with a slight average negative reaction of -0.32% over the past five tagged events.

Recent Company History

Over the past several quarters, Boston Scientific has repeatedly issued combined "conferences,earnings" announcements outlining participation in major healthcare conferences and scheduling quarterly earnings calls. Prior releases on Jan 2, 2025, Apr 1, 2025, Jul 1, 2025, Sep 2, 2025, and Jan 2, 2026 all followed the same template: setting dates and times, naming senior presenters, and confirming that webcasts and replays would be available. Price reactions around these events have been modest, with single‑day moves ranging roughly between about -2.45% and 1.10%, suggesting these notices are treated as routine housekeeping rather than major catalysts.

Historical Comparison

-0.3% avg move · In the past tagged "conferences,earnings" announcements, BSX saw an average move of -0.32% on the da...
conferences,earnings
-0.3%
Average Historical Move conferences,earnings

In the past tagged "conferences,earnings" announcements, BSX saw an average move of -0.32% on the day, with generally modest single‑day reactions around routine scheduling news.

The pattern shows a consistent cadence of quarterly earnings calls paired with major conference appearances, reinforcing a stable investor‑relations playbook rather than signaling step‑change corporate developments.

Market Pulse Summary

This announcement sets logistics for Boston Scientific’s Q1 2026 earnings discussion, confirming tha...
Analysis

This announcement sets logistics for Boston Scientific’s Q1 2026 earnings discussion, confirming that results for the quarter ended March 31, 2026 will be released on April 22, 2026 with an 8:00 a.m. ET webcast and replay. It mirrors prior "conferences,earnings" notices that averaged a modest -0.32% price move, suggesting these are treated as routine. Investors may focus on the forthcoming financial release, recent acquisition-related filings, and prior clinical data updates as the more material catalysts.

AI-generated analysis. Not financial advice.

MARLBOROUGH, Mass., March 30, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2026, on Wednesday, April 22, 2026, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Jon Monson, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on April 22 prior to the conference call.

A live webcast and replay for the event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.  

CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com

Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-first-quarter-2026-results-302727378.html

SOURCE Boston Scientific Corporation

FAQ

When will Boston Scientific (BSX) discuss Q1 2026 results?

The conference call is scheduled for April 22, 2026 at 8:00 a.m. ET. According to Boston Scientific, the company will issue a news release with first-quarter results before the call and host a live webcast with a replay available afterward.

Who will host Boston Scientific's (BSX) Q1 2026 conference call?

The call will be hosted by Mike Mahoney and Jon Monson. According to Boston Scientific, Mahoney serves as chairman and CEO and Monson is executive vice president and CFO, who will discuss financial results and business highlights.

Where can investors access Boston Scientific (BSX) April 22, 2026 webcast?

Investors can access the live webcast and replay at https://investors.bostonscientific.com. According to Boston Scientific, the replay will be available approximately one hour after the event ends.

Will Boston Scientific (BSX) release Q1 2026 financial results before the call?

Yes — the company will issue a news release with first-quarter results prior to the April 22, 2026 conference call. According to Boston Scientific, the release precedes the webcast so participants can review results in advance.

What topics will Boston Scientific (BSX) cover on the April 22, 2026 call?

The call will cover financial results and business highlights for Q1 2026. According to Boston Scientific, senior executives will present results and discuss operational and financial highlights during the webcast.
Boston Scien Cp

NYSE:BSX

View BSX Stock Overview

BSX Rankings

BSX Latest News

BSX Latest SEC Filings

BSX Stock Data

102.80B
1.48B
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MARLBOROUGH